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ABSTRACT
This is a case report of a 37-year-old female who presented with deranged liver function tests, epigastric pain, fevers, vomiting, mild hypertension, 
and proteinuria in pregnancy. This was on a background of gestational diabetes, dyspepsia, and previous cholecystectomy. This case report highlights 
the importance of considering various causes of liver pathology during pregnancy besides those specifically associated with pregnancy, as well as the 
necessity of early specialist input to investigate symptomatic choledocholithiasis in pregnancy.
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INTRODUCTION
Gallstone-related complications are relatively common during 
pregnancy, with reports of biliary sludge in 5–31% and cholelithiasis 
in 2–11% of expectant mothers [1]. About 1% of these women will 
develop complications secondary to cholelithiasis, which may lead 
to increased fetal and maternal morbidity and mortality (Ko et al., 
2005) [2]. This case highlights the importance of considering a broad 
spectrum of hepatobiliary disorders during pregnancy, including 
choledocholithiasis and considering urgent endoscopic retrograde 
cholangiopancreatography (ERCP) as a safe option for those women 
with symptomatic complicated cholechodolithiasis.
CASE REPORT
A 35-year-old female, Gravida 5, Para 4, presented to antenatal clinic at 
31 weeks of gestation with 3 days of epigastric pain and vomiting. She 
had a body mass index of 47 and a background of depression, migraine, 
dyspepsia, and previous cholecystectomy. She developed gestational 
diabetes during her pregnancy and received growth scans which 
were all normal. As she was high risk for thromboembolic disease in 
pregnancy, she was on prophylactic enoxaparin.
Initial observations revealed borderline hypertension and urine 
dipstick showed ketones (4+) and proteinuria, but no glycosuria. She 
was admitted pending further tests for blood pressure monitoring, 
IV hydration, and antiemetics. On examination, she complained of 
epigastric pain, without any positive abdominal findings.
Liver function tests showed an alanine transferase (ALT) of 501 U/L, 
with the rest of the parameters being normal along with normal renal 
function, coagulation, amylase, autoimmune antibody, and viral screen. 
Arterial blood gases showed a metabolic alkalosis consistent with 
protracted vomiting and hypovolemia. Cardiotocogram was normal 
and an abdominal ultrasound scan did not reveal a specific cause for 
the high ALT levels.
The raised ALT in association with epigastric pain, proteinuria, and 
hypertension raised the possibility of pre-eclampsia complicated by 
hemolysis, elevated liver enzymes, and low platelets syndrome. The lack 
of associated symptoms such as upper abdominal pain, decrease in urine 
output, persistent headache or blurring of vision, and tendency to bleed 
as well as relatively normal bloods made this less likely. Hepatobiliary 
causes of this presentation were also considered, and specialist input 
was sought. Amongst these differential diagnosis was acute fatty liver 
disease of pregnancy (AFLP), which is a relatively uncommon but life-
threatening cause of acute liver failure in pregnancy with mortality rates 
for fetus and mother ranging between 1-20% [3]. However, the absence 
of hypoglycemia or a fulminant course of acute liver failure effectively 
excluded this important differential diagnosis. Obstetric cholestasis was 
felt to be unlikely given the LFT pattern, absence of pruritus, and presence 
of epigastric pain. The patient’s symptoms and associated biochemical 
abnormalities were thought to be consistent with complicated gallstone 
disease and specialist opinion was sought [4]. Choledocholithiasis 
was considered in the differential diagnosis (despite previous 
cholecystectomy and negative abdominal ultrasound scan). Other 
diagnoses such as non-alcoholic fatty liver disease, viral and autoimmune 
hepatitis are usually not associated with severe abdominal pain and 
were excluded by relevant blood tests. At the suggestion of the specialist 
gastroenterologist, a magnetic resonance cholangiopancreatography 
(MRCP) scan (Fig. 1) was requested and carried out urgently.
This confirmed the presence of multiple bile duct calculi following 
which an ERCP was performed. Endoscopic sphincterotomy was carried 
out, followed by successful extraction of all stones and common bile 
duct (CBD) clearance. Following stone extraction, a biliary pigtail stent 
was inserted to ensure uncomplicated recovery and to reduce the risk 
of recurrent problems for the remainder of the pregnancy. Prophylactic 
antibiotics were administered as per guidelines [5].
The patient’s symptoms and blood parameters improved rapidly 
following ERCP and she was discharged home within a few days 
(Fig. 2-4). She was induced at 38 weeks due to obstetric complications, 
had a quick vaginal delivery following that, and her postnatal follow-up 
was uneventful.
DISCUSSION
Cholelithiasis can occur in pregnancy due to hormone-related changes 
in cholesterol secretion, causing oversaturation of the bile compared to 
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bile acids and phospholipids which increases with parity [6]. Up to 10% 
of patients develop stones or sludge over the course of each pregnancy, 
with obesity in particular being a risk factor [2].
Choledocholithiasis complicated by ascending cholangitis is a serious 
and potentially life-threatening condition in pregnancy, causing preterm 
labor in up to 10% of cases [7]. It is, therefore, recommended that ERCP 
is considered and promptly undertaken to avoid potentially serious 
complications and adverse outcomes [7]. Elective or semi-elective 
cholecystectomy after successful ERCP can usually be deferred for 
after delivery, as it can lead to fetal compromise [8]. Despite concerns 
regarding the harmful effects of ionizing radiation to the fetus, several 
retrospective case series have endorsed the safety of this approach 
during pregnancy (Tang et al., 2009) [9].
The American Society of Gastrointestinal Endoscopy guidance 
suggests that ERCP is a safe procedure in the setting of symptomatic 
cholechodolithiasis and its complications during pregnancy [10]. 
The Society of American Gastrointestinal and Endoscopic Surgeons 
guidelines recommend either ERCP or laparoscopic cholecystectomy 
with CBD exploration for choledocholithiasis in pregnancy based 
on availability and local expertise [7], while European guidelines 
recommend ERCP during pregnancy for the treatment of 
choledocholithiasis and its complications (The Italian Association for 
the Study of the Liver [AISF] 2016) [11].
CONCLUSION
There is a broad differential diagnosis for obstetric patients presenting 
with deranged liver tests and epigastric pain and time is of the essence 
in preventing serious and potentially fatal complications for the mother 
and fetus. Early involvement of a hepatobiliary specialist and early 
specific cross-sectional imaging in the form of MRCP is essential for a 
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Fig. 1: Magnetic resonance cholangiopancreatography 
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Fig. 2: Value of elevated alanine transferase along with 
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Fig. 3: Value of elevated bile acids along with normal ranges 















Fig. 4: Value of elevated bile acids along with normal ranges 
before and after magnetic resonance cholangiopancreatography
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